CIK 0001699031
- Non-accelerated filer
- Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863673636
- Phone
- +1 833-694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,155,660
- in 8 filings, $10.5M under 10b5-1 plans
Net −$15,155,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | CHASE WILLIAM J Director | Grant or award | +153 | $135.46 | $21K | 43,131 |
| 2026-07-15 | CHASE WILLIAM J Director | Grant or award | +276 | $74.36 | $21K | 42,978 |
| 2026-06-18 | CHASE WILLIAM J Director | Grant or award | +5,491 | $63.74 | $350K | 42,702 |
| 2026-04-15 | CHASE WILLIAM J Director | Grant or award | +408 | $49.79 | $20K | 37,211 |
| 2026-01-15 | CHASE WILLIAM J Director | Grant or award | +213 | $97.44 | $21K | 36,803 |
| 2025-10-15 | CHASE WILLIAM J Director | Grant or award | +275 | $75.52 | $21K | 36,590 |
| 2025-07-15 | CHASE WILLIAM J Director | Grant or award | +533 | $38.53 | $21K | 36,315 |
| 2025-05-29 | CHASE WILLIAM J Director | Grant or award | +6,082 | $41.10 | $250K | 35,782 |
| 2025-04-15 | CHASE WILLIAM J Director | Grant or award | +784 | $25.94 | $20K | 29,700 |
| 2025-01-15 | CHASE WILLIAM J Director | Grant or award | +1,182 | $17.58 | $21K | 28,916 |
| 2024-10-30 | CHASE WILLIAM J Director | Grant or award | +210 | $13.62 | $3K | 27,734 |
| 2024-10-15 | CHASE WILLIAM J Director | Grant or award | +1,054 | $14.01 | $15K | 27,524 |
| 2024-06-25 | CHASE WILLIAM J Director | Grant or award | +26,470 | 26,470 |
Page 1 of 1 · 13 trades